Appointment of Mrs. D. Lakshmi Jyothsna as Company Secretary & Compliance Officer of the company w.e.f. 01-05-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs' board, at its meeting on April 30, 2025, approved raising the authorised share capital from Rs. 16 crore to Rs. 25 crore. It also approved issuing up to 38,40,000 equity shares at Rs. 10 each to non-promoters on a preferential basis, and up to 45,50,004 shares on a swap basis to acquire a 28.62% stake in Qrops Advisory Services Pvt Ltd (an MSME consulting firm with Rs. 22.26 crore turnover in FY25) at a total consideration of Rs. 4.55 crore. The company also amended its main objects to include new business areas such as biofuels, green technology, IT, e-commerce, clinical research, and advisory services. An EGM is scheduled for May 23, 2025 to seek shareholder approval. Additionally, Mrs. D. Lakshmi Jyothsna was appointed as Company Secretary and Compliance Officer effective May 1, 2025.
Existing shareholders will face significant dilution if both preferential issues are approved, but the acquisition involves no cash outflow and could bring synergies in pharma R&D and capital advisory. The expansion of main objects signals a strategic shift beyond pure healthcare into diversified sectors, pending shareholder approval at the May 23 EGM.